Buqu Hu

2026

• Correction: Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway

  Hu B, Guo P, Bar-Joseph I, Imanishi Y, Jarzynka M, Bogler O, Mikkelsen T, Hirose T, Nishikawa R, Cheng S. Correction: Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway. Oncogene 2026, 45: 3021-3022. PMID: 42393289, DOI: 10.1038/s41388-026-03882-x.

  Commentaries, Editorials and Letters

• Stepwise Protocol for Alternative Splicing Analysis in Single-Cell SMART-Seq2 RNA-Seq Data

  Walker M, Hu B, Cheng S, Song X. Stepwise Protocol for Alternative Splicing Analysis in Single-Cell SMART-Seq2 RNA-Seq Data. Bio-protocol 2026, 16: e5735. PMID: 42367213, PMCID: PMC13293989, DOI: 10.21769/bioprotoc.5735.

  Peer-Reviewed Original Research

  Citations

• PPM1G‒MET axis sustains AKT signaling to drive Twist‐associated EMT and drug resistance in hepatocellular carcinoma

  Wu W, Lin S, Zhou C, Hu J, Liu K, Xu Y, Ding Z, Luo M, Hu B. PPM1G‒MET axis sustains AKT signaling to drive Twist‐associated EMT and drug resistance in hepatocellular carcinoma. View 2026 DOI: 10.1002/viw.20260024.

  Peer-Reviewed Original Research

• Global Advances in Hepatocellular Carcinoma Research and Therapy in 2025

  Hu B, Gao Q. Global Advances in Hepatocellular Carcinoma Research and Therapy in 2025. Cancer Innovation 2026, 5: e70059. PMID: 42005557, PMCID: PMC13084537, DOI: 10.1002/cai2.70059.

  Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements

  Citations

• The epidermal growth factor receptor regulates bacterial clearance in cystic fibrosis airway neutrophils

  Rasmussen L, Luthra D, Moncada-Giraldo D, Lewis C, Soto-Vazquez Y, Li Z, Hu B, Dobosh B, Stacks D, Koff J, Gaggar A, Tirouvanziam R, Margaroli C. The epidermal growth factor receptor regulates bacterial clearance in cystic fibrosis airway neutrophils. Journal Of Clinical Investigation 2026, 136: e198292. PMID: 41979898, PMCID: PMC13262706, DOI: 10.1172/jci198292.

  Peer-Reviewed Original Research

  Altmetric

  MeSH Keywords and Concepts

• An EGFR co-amplified lncRNA HELDR promotes glioblastoma malignancy through KAT7-driven gene programs

  Yu X, Song X, Schäfer R, Meng Q, Tiek D, Wu R, He Q, Walker M, Cao Q, Yang R, Hu B, Cheng S. An EGFR co-amplified lncRNA HELDR promotes glioblastoma malignancy through KAT7-driven gene programs. Nature Cell Biology 2026, 28: 972-985. PMID: 41896311, PMCID: PMC13086523, DOI: 10.1038/s41556-026-01924-w.

  Peer-Reviewed Original Research

  Citations

  Altmetric

  MeSH Keywords

• Tumor-associated astrocytes augment cholesterol synthesis to support glioblastoma growth through alternatively spliced QKI isoforms

  Wu R, Yu X, Song X, He Q, Walker M, Sisbarro D, Horbinski C, Tiek D, Hu B, Zhang N, Cheng S. Tumor-associated astrocytes augment cholesterol synthesis to support glioblastoma growth through alternatively spliced QKI isoforms. Neuro-Oncology 2026, 28: 1163-1178. PMID: 41703645, PMCID: PMC13186460, DOI: 10.1093/neuonc/noag030.

  Peer-Reviewed Original Research

  Altmetric

  MeSH Keywords

• Tumour–brain crosstalk restrains cancer immunity via a sensory–sympathetic axis

  Wei H, Yu C, Hu B, Zeng X, Ichise H, Li L, Wang Y, Wang R, Germain R, Chang R, Jin C. Tumour–brain crosstalk restrains cancer immunity via a sensory–sympathetic axis. Nature 2026, 650: 1007-1016. PMID: 41639447, PMCID: PMC12935554, DOI: 10.1038/s41586-025-10028-8.

  Peer-Reviewed Original Research

  Citations

  Altmetric

  MeSH Keywords and Concepts

• Epidermal growth factor receptor regulates Beclin-1 in hyperoxic acute lung injury

  Harris Z, Korde A, Khoury J, Manning E, Stanley G, Shin Y, Mitchell K, von der Schulenburg A, Sun Y, Hu B, Shin H, Joerns J, Clark B, Placek L, Unutmaz D, Moldobaeva A, Sharma L, Sauler M, Rajagopalan G, Zhang X, Wang H, Ghaedi M, Kang M, Koff J. Epidermal growth factor receptor regulates Beclin-1 in hyperoxic acute lung injury. BMJ Open Respiratory Research 2026, 13: e003323. PMID: 41592865, PMCID: PMC12853440, DOI: 10.1136/bmjresp-2025-003323.

  Peer-Reviewed Original Research

  MeSH Keywords and Concepts

• Stable Disease without Tumor Shrink Cannot Benefit from Surgery following Immune-Based Therapy in Potentially Resectable Hepatocellular Carcinoma

  He T, Xu B, Yang Z, Zhou S, Wang Z, Wang L, Zhong C, Shi H, Li H, Hu B, Zhu X, Shen Y, Gao Q, Zhou J, Fan J, Sun H, Huang C. Stable Disease without Tumor Shrink Cannot Benefit from Surgery following Immune-Based Therapy in Potentially Resectable Hepatocellular Carcinoma. Liver Cancer 2026, 1-13. PMID: 41815110, PMCID: PMC12975274, DOI: 10.1159/000550497.

  Peer-Reviewed Original Research

  Citations